Medcxy

Product dossierBuilt from registrations, label text and platform-curated data

时凝萃注射用聚左旋乳酸填充剂

Ask about this product

时凝萃 is a PLLA product (Class III device), registered by 北京京宇一美生物科技有限责任公司. Linked registrations: China 国械注准20263130522. First approved in China on 2026-03-11 (国械注准20263130522). Data as of 2026-10-24.

  • Regulatory classPLLA · Class III device
  • Holder北京京宇一美生物科技有限责任公司
  • JurisdictionsCN
  • Updated2026-10-24 · v1

Registration and basics are public; findings and prices need an account

Registration and basics

时凝萃

Product
Regulatory class
Class III device
Category
PLLA
China · NMPA device registration
国械注准20263130522
Name on registration
注射用聚左旋乳酸填充剂
Registrant
北京京宇一美生物科技有限责任公司
First approval
2026-03-11
This certificate issued
2026-03-11
Valid until
2031-03-10
Models and sizes
YM01100：100mg/瓶、YM01150：150mg /瓶、YM01300：300mg /瓶
Checked against official page
2026-10-23

Public: fields from the registration record.

Label facts by jurisdiction

What each jurisdiction's label says for the same attribute; gaps are marked Not reported, irrelevant ones N/A

No data yet

Registration timeline

  1. CN

    国械注准20263130522 first approved

  2. CN

    国械注准20263130522 change

    首次获批（受理号 CQZ2500682；2026年03月12日医疗器械批准证明文件送达信息）

  3. CN

    国械注准20263130522 valid until

First approval, this certificate's issue date (updated after renewals or changes), changes and expiry are listed separately; a missing first approval means it was not obtained from an official source. Up to 6 recent changes per registration; click the number for the full record.

Cross findings · Price observations

Sign in to see findings and prices

Findings and prices stay out of indexable pages.

Sign in to view

Recent changes

1
  • 国械注准20263130522: 首次获批（受理号 CQZ2500682；2026年03月12日医疗器械批准证明文件送达信息）2026-03-11

Sources

1